The chemical class referred to as ADAM9 Inhibitors encompasses a diverse group of molecules and compounds that have been developed and studied for their ability to modulate the activity of A Disintegrin and Metalloproteinase 9 (ADAM9). ADAM9 is a transmembrane protein involved in various cellular processes, including cell adhesion, proteolysis, and signaling. ADAM9 Inhibitors are specifically designed to interact with ADAM9 or related pathways, aiming to interfere with its proteolytic and functional activities. By targeting ADAM9, these inhibitors offer a means to investigate and manipulate the intricate mechanisms that govern cellular interactions and molecular processes.
The study of ADAM9 Inhibitors contributes to advancing our understanding of the roles played by ADAM9 in cell biology, shedding light on its involvement in cellular communication and extracellular matrix remodeling. Ongoing research endeavors continue to elucidate the mechanisms of action and broader implications associated with ADAM9 Inhibitors, thereby enhancing our insights into the molecular intricacies that underlie fundamental cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Batimastat | 130370-60-4 | sc-203833 sc-203833A | 1 mg 10 mg | $179.00 $377.00 | 24 | |
A broad-spectrum matrix metalloproteinase (MMP) inhibitor that can target ADAM9 due to its inhibitory effects on MMPs. | ||||||
GI 254023X | 260264-93-5 | sc-490114 | 1 mg | $166.00 | 1 | |
This compound inhibits both ADAM9 and MMPs, suggesting its potential as a dual inhibitor of metalloproteinases. | ||||||
GW 280264X | 866924-39-2 | sc-507540 | 5 mg | $720.00 | ||
An inhibitor that has been reported to target both ADAM9 and ADAM10, influencing their proteolytic activities. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
Originally developed as a proteasome inhibitor, PR-171 has also been found to inhibit ADAM9 and reduce its enzymatic activity. | ||||||
SB-3CT | 292605-14-2 | sc-205847 sc-205847A | 1 mg 5 mg | $102.00 $388.00 | 15 | |
Originally developed as a matrix metalloproteinase inhibitor, SB-3CT has been found to inhibit ADAM9 and reduce its enzymatic activity. | ||||||
N,N′-Dimethylthiourea | 534-13-4 | sc-250537 sc-250537A | 5 g 100 g | $38.00 $89.00 | ||
This compound has been shown to inhibit ADAM9 and impact its proteolytic function. | ||||||